record date: 2064-07-28 team 2 internal medicine intern admission notename:  ethridge, claytonmr#:  8381729admit date: 7/28/64attending:  dr. tomlinadmitting intern: ursula quiles, mdcode: fullsource: medical record, patientchief complaint: fistula clothistory of present illness:  pt is a 59 yo khazakhstani male, with h/o htn, dm, mucormycosis, and esrd on hd presenting with a thrombosed avf in his left arm, established in april of 2064 by dr. jordon.  the patient has a history of multiple problems with access (clots, stenoses), requiring frequent thrombectomies and revisions.   the patient first noticed a problem on july 23, and by the 24th he said that "the access had collapsed." on july 25, interventional radiology attempted to thrombectomize the clot, with no success, requiring placement of a new tunneled catheter in left ij to allow dialysis.  at present, patient is on the or waiting list for tomorrow, for thrombectomy/revision.  of note, patient was admitted in april of 2064 after a nurse at the mclaren hospital detected a new cardiac murmur.  pt was found to have a ra thrombus by echo, presumed to be a complication from a prior catheter, started on a heparin gtt and transitioned to coumadin.  ros: no fever/chills, ha, sob, cp, n/v/d (though states that stomach sometimes "sensitive").past medical history: dm - type 2htnesrd on hd mwf, with h/o multiple problems with access, cr baseline 4s/p extensive bowel resection for mucormycosis, june 2062 (gastrectomy, esophagojejunostomy, splenectomy, distal pancreatectomy, segmental transverse colectomy)	s/p l thr    s/p resection arthroplasty of left femoral head and acetabulum for fungal infection (mucomycosis above, june 2062)r atrial thrombus by echo in 4/63allergies: nafcillin- rashpenicillin- rashmedications (upon admission)      remeron (mirtazapine)   15 mg (15mg tablet take 1) po qhs       nexium (esomeprazole)   20 mg (20mg capsule dr take 1) po qd       trazodone   50 mg (50mg tablet take 1) po qhs       colace (docusate sodium)   100 mg (100mg tablet take 1) po tid       norvasc (amlodipine)   10 mg (10mg tablet take 1) po qd       diovan (valsartan)   80 mg (80mg tablet take 1) po qd       insulin regular human   sc        nephrocaps   1 capsule po qd       renagel (sevelamer)   806 mg (403mg capsule take 2) po tid       folate (folic acid)   1 mg (1mg tablet take 1) po qd       calcium carbonate (500 mg elemental ca++)   1250 mg po ac       warfarin sodium   2.5 mg (2.5mg tablet take 1) po qpmsocial history:  patient is a native of kazakhstan, who moved to the ukraine to study electrical mechanics at openmarket inc.  he is currently unable to pursue this field, due to his debilitated state, however he would like to try to intern, when he feels up to it.  he lives in the mclaren hospital in kemmerer (a facility for homeless individuals.)  no tobacco, etoh, illicits. family history: non-contributory.exam: vitals:  bp 121/62  hr 78 rr 16  t 97.5 o2 sat 100% ragen:  heent: perl, op without erythema, exudates; mucous membranes moist; no scleral icteruspulm: cta with good air movement bilat.; no c/w/rcor/cardiac: rrr nl. s1,s2; no m/g/r, neck veins flatabdomen: s/nt/nd; +bs throughout; no hsm, palpable/pulsatile massesextremity: no c/c/e; distal pulses 2+ bilat; left le shorter than right and internally rotatedneurological: cn ii-xii grossly intact, strength 5/5 all major muscle groups; dtr's 2+ bilat. ue/le, laboratory hematology educare-pullman  blood          27-jul-2064 16:10  accession# 8911z65654wbc                              8.0                       (4.5-11.0)     th/cmmhct                              34.7             l        (41.0-53.0)    %hgb                              11.0             l        (13.5-17.5)    gm/dlrbc                              3.55             l        (4.50-5.90)    mil/cmmplt                              255                       (150-350)      th/cummmcv                              98                        (80-100)       flmch                              31.1                      (26.0-34.0)    pg/rbcmchc                             31.8                      (31.0-37.0)    g/dlrdw                              15.3             h        (11.5-14.5)    %retic                            2.6              h        (0.5-2.5)      %chemistryeducare-pullman  blood          27-jul-2064 16:10  accession# 8911z65654plasma sodium                    135                       (135-145)      mmol/lplasma potassium                 5.0              h        (3.4-4.8)      mmol/lplasma chloride                  100                       (100-108)      mmol/lplasma carbon dioxide            19.4             l        (23.0-31.9)    mmol/lcalcium                          7.7              l        (8.5-10.5)     mg/dlphosphorus                       5.3              h        (2.6-4.5)      mg/dlplasma urea nitrogen             74               h        (8-25)         mg/dlplasma creatinine                7.7              h        (0.6-1.5)      mg/dlplasma glucose                   113              h        (70-110)       mg/dlalbumin                          3.7                       (3.3-5.0)      g/dlparathyroid hormone              187              h        (10-60)        pg/mlekg: nsr at 75-80, normal axis, normal intervals. no st changes or twis compared to prior in april 2064 (j point elevation in v1-v3 in both).  cardiac studiesecho: 4/25/2064 ef 65%, lvh, mobile mass (27x22mm) in ra, small pericardial effusion. radiologycxr july 27, 2064impression: dual lumen dialysis catheter from the left jugular region to the right atrium without pneumothorax, hematoma, or pleural effusion. no new or enlarging infiltrates or masses.  slight fullness in the region of the right thyroid gland.	assessment and plan: 59 yo kazakhstani male, with htn, dm, and esrd on hd, and h/o access issues (multiple thromboses, stenoses requiring frequent revisions) and admitted with clotted left avf for revision/thrombectomy in the or.  1.	access: clotted l avf, functional left ij tunneled cath.a.	on waiting list with dr. jordon for procedure tomorrowi.	npo p mnii.	hold coumadinb.	iv access for r arm. 2.	esrd on hda.	patient for dialysis on monday, if still inpatient.b.	contine nephrocaps, renagel, cacarbonate, 3.	dm: pt reports well-controlled, rarely c fs>200a.	fs qam, qpm before breakfast and dinner; reg ins sliding scaleb.	diabetic diet4.	htna.	continue outpatient regimen of norvasc and diovanb.	note: these meds are held on dialysis days (mwf)5.	h/o r atrial clota.	inr goal 1.8-2.5b.	consider repeat echo, to evaluate clot stabilization and to better plan anticoagulation regimenc.	follow coags6.	elevated k to 5.8    5.0 on 7/27.a.	check pm labs, assess need for kayexalate. 7.	low hct (lowest since 1/64)a.	anemia panel8.	prophylaxisa.	nexium, on coumadin tx (though held tonight)9.	code status: full code ursula quiles, mdteam 2 intern#50684